000 01340 a2200385 4500
005 20250512034457.0
264 0 _c19870520
008 198705s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.31.2.219
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTanaka, S K
245 0 0 _aIn vitro evaluation of tigemonam, a novel oral monobactam.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cFeb 1987
300 _a219-25 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAcinetobacter
_xdrug effects
650 0 4 _aBacteria
_xdrug effects
650 0 4 _aEnterobacteriaceae
_xdrug effects
650 0 4 _aHaemophilus influenzae
_xdrug effects
650 0 4 _aKinetics
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aMonobactams
_xmetabolism
650 0 4 _aNeisseria gonorrhoeae
_xdrug effects
650 0 4 _aPseudomonas aeruginosa
_xdrug effects
650 0 4 _abeta-Lactamases
_xmetabolism
700 1 _aSummerill, R A
700 1 _aMinassian, B F
700 1 _aBush, K
700 1 _aVisnic, D A
700 1 _aBonner, D P
700 1 _aSykes, R B
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 31
_gno. 2
_gp. 219-25
856 4 0 _uhttps://doi.org/10.1128/AAC.31.2.219
_zAvailable from publisher's website
999 _c3111249
_d3111249